AXDX Accelerate Diagnostics Inc

Accelerate Diagnostics Inc is an in vitro diagnostics company, dedicated in providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections.

$4.75  -0.22 (-4.43%)
As of 12/06/2021 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  02/01/2001
Outstanding shares:  61,498,695
Average volume:  605,152
Market cap:   $308,108,462
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00430H102
ISIN:        US00430H1023
Sedol:      B8QZWL9
Valuation   (See tab for details)
PE ratio:   -4.14
PB ratio:   26.58
PS ratio:   26.68
Return on equity:   185.70%
Net income %:   -639.22%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy